Onyia Jude 4

What Happened

• Onyia Jude, Chief Scientific Officer of Neurocrine Biosciences, reported gifting 2,441 shares of NBIX on June 5, 2026. The transaction is reported as a gift (code G) with a reported price of $0.00 and total proceeds $0 since it was not a market sale.

Key Details

• Transaction date and type: June 5, 2026 — Gift (G) of 2,441 shares; price reported $0.00.
• Reported proceeds: $0 (gift/charitable contribution; no value received).
• Shares owned after transaction: not specified in the provided filing.
• Footnote: F1 confirms this was a gift/charitable contribution effective June 5, 2026 and not a market transaction.
• Filing date/timeliness: Form 4 was filed on June 9, 2026 — within the typical two-business-day reporting window for Section 16 insiders.

Context

• Gifts are not market trades and do not directly indicate the insider’s view on the company’s stock; they are often for personal or charitable planning. No option exercises, sales for cash, or 10% owner issues are involved in this report.